Sep 5, 2022 Posters & Publications
AUTHORS: Jonathan S. Wall1, Emily B. Martin1, Alan Stuckey1, Dustin Powell2, Tina Richey1, Angela Williams1, R. Eric Heidel3, Ronald Lands1, Stephen J. Kennel1 Departments of Medicine1, Radiology2 and Surgery3, University of Tennessee Graduate School of Medicine, TN,...
Sep 5, 2022 Posters & Publications
AUTHORS: Emily B. Martin1, Alan Stuckey1, Dustin Powell2, Ronald Lands2, Spencer Guthrie3, Stephen J. Kennel1, and Jonathan S. Wall1 1 University of Tennessee Graduate School of Medicine, Knoxville, TN, USA 2 University of Tennessee Medical Center, Knoxville, TN, USA...
Aug 22, 2022 Press Releases
PDF Version SAN FRANCISCO, Calif. – August 22, 2022 – Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced that new data across the Company’s...
Aug 8, 2022 Press Releases
PDF Version SAN FRANCISCO, Calif. – August 8, 2022 – Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, announced today that the U.S. Food and Drug...
Jun 14, 2022 Press Releases
PDF Version AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosis AT-01 visualizes and quantifies organ-specific changes in amyloid load over time AT-01 detected patients with diverse types of systemic amyloidosis, by...
